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Testicular metabolismDiabetes mellitus (DM) is one of the greatest public health threats in modern societies. Although during a
few years it was suggested that DM had no signiﬁcant effect in male reproductive function, this view has
been challenged in recent years. The increasing incidence of DM worldwide will inevitably result in a higher
prevalence of this pathology in men of reproductive age and subfertility or infertility associated with DM is
expected to dramatically rise in upcoming years. From a clinical perspective, the evaluation of semen param-
eters, as well as spermatozoa deoxyribonucleic acid (DNA) integrity, are often studied due to their direct
implications in natural and assisted conception. Nevertheless, recent studies based on the molecular
mechanisms beyond glucose transport in testicular cells provide new insights in DM-induced alterations in
male reproductive health. Testicular cells have their own glucose sensing machinery that react to hormonal
ﬂuctuations and have several mechanisms to counteract hyper- and hypoglycemic events. Moreover, the
metabolic cooperation between testicular cells is crucial for normal spermatogenesis. Sertoli cells (SCs),
which are the main components of blood–testis barrier, are not only responsible for the physical support
of germ cells but also for lactate production that is then metabolized by the developing germ cells. Any alter-
ation in this tied metabolic cooperation may have a dramatic consequence in male fertility potential. There-
fore, we present an overview of the clinical signiﬁcance of DM in the male reproductive health with emphasis
on the molecular mechanisms beyond glucose ﬂuctuation and transport in testicular cells.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Diabetes mellitus (DM) is one of the most prominent public health
threats in modern societies and its prevalence is rapidly increasing. In
2000, the World Health Organization (WHO) reported that there
were about 171 million people with DM, which represented a 60% in-
crease relatively to 1995 [1]. A recent report by Wild et al. predicted
that, if obesity rates are maintained constant, in 2030 there will be
about 300 million individuals affected by DM, which could represent
a 39% increase comparatively to 2000 [2]. However, the statistics that
point to an overall 4.4% prevalence in the world population could be
underestimated since the factors known to be responsible for the
disease progression, such as obesity and lifestyle habits, may aggra-
vate these numbers [2].
A closer look into fertility rates of modern societies reveals that
the increased incidence of DM has been closely associated with fallinges Research Centre, Faculty of
fante D. Henrique, 6200-506
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l rights reserved.birth rates and fertility [3,4]. This is due to a disturbing increase of di-
abetic men in reproductive age. The great majority of patients with
type 1 diabetes (T1D) are diagnosed before the age of 30 [5] and
there is an alarming number of childhood and adolescent with T1D
and type 2 diabetes (T2D) [6]. Moreover, western diets, lifestyle
habits and obesity in young individuals strongly contribute for the in-
creasing incidence of T2D in youth [7]. In Japan, there are already four
times more adolescents with T2D than T1D [8], and, in USA, more
than one third of the new DM diagnostics are in young adolescents
[9]. Although there is no doubt that the disease is responsible for
several pathological and biochemical alterations that reduce male fer-
tility, the real impact of DM on male reproductive health remains ob-
scure and is a matter of great debate. Sexual disorders, such as erectile
dysfunction [10] or retrograde ejaculation [11,12], are known to occur
in diabetic individuals and usually end-up in a reduction of sexual
appetite that is often attributed to lethargy and a certain degree of
tiredness associated to the hyperglycemic state [13]. The decline in
reproductive health of male diabetics can be apparently attenuated
in a “well-controlled” patient but the discussion on the molecular
mechanisms behind such processes is scarce. Multiple molecular
mechanisms and pathways are affected by DM with dramatic conse-
quences to male reproductive function. The endocrine control of
spermatozoa production event, spermatogenesis, is in fact severely
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betic men can be compromised. This is a direct consequence of the
unique characteristics of glucose metabolism that testicular cells
present. Their glucose sensing machinery, hormonal control and
speciﬁc mechanisms to counteract hyper- and hypoglycemia play a
crucial role in the subfertility and/or infertility associated to DM.
Several clinical and animal studies have been focused on themolec-
ularmechanisms responsible for the alterations induced by DM inmale
reproductive potential but much remains to be discussed. Important
metabolic pathways, beyond glucose transport to the cells, remain
undisclosed. Moreover, insulin (dys)function in male diabetic individ-
uals is scarcely debated in the interpretation of themechanisms respon-
sible for male DM-induced subfertility/infertility. Therefore, we aim to
present an up-to-date view on the male reproductive health of diabetic
individuals and discuss the molecular mechanisms and pathways al-
tered by DM beyond the expected increase in glucose transport to tes-
ticular cells. The role of insulin signaling will also be discussed. Finally,
future directions in the study of themolecular mechanisms responsible
for DM-induced male reproductive dysfunction will be presented.
2. Diabetes mellitus at a glance
Diabetes is a chronic, metabolic disease characterized by hypergly-
cemia that can result from defects in insulin secretion and/or insulin ac-
tion [17]. Moreover, there is a severe alteration in carbohydrate, lipid
and proteinmetabolism [17] that causes several systemic complications
and co-morbidities such as renal failure or hypertension [18,19]. There-
fore, the origin of the DM-induced dysfunctions is a result ofmultifacto-
rial causes that cannot be disregarded and highly complicates the study
of this disease. The vast majority of the diagnosed DM cases are classi-
ﬁed as T1D or T2D. In the ﬁrst category, there is an absolute deﬁciency
of insulin secretion,while in the second, the cause can be a combination
of insulin resistance and insufﬁcient insulin secretion [17]. Noteworthy,
in T2D, the clinical symptoms are frequently detected only in an ad-
vanced phase of the disease, allowing the progression of functional
changes in cells and tissues that may not be reverted even when a
correct therapy is achieved [20]. One must also note that although the
glycemic management in diabetic patients is crucial to reduce the
development of several complications, it does not eliminate all the un-
desirable effects [21,22]. Recent reports have questioned the safety of in-
sulin [23] since some of the most important side-effects that diabetic
patients suffer are related to the occurrence of hypoglycemic events,
even if they occur transiently [24,25]. Nevertheless, insulin remains the
most powerful antihyperglycemic agent available although it is often
combined with other antihyperglycemic agents to achieve euglycemia
in diabetic patients. Noteworthy, recent studies reported that adults
with DM can have a poor glycemic control due to intentionally missed
insulin therapy [26] thus evidencing that clinical studies can, sometimes,
be misled by this factor.
The complexity of DM diagnostic, especially in obese patients, led
the researchers to establish an intermediate state, often called as pre-
diabetes, where the patients present mild glycemia that does not
meet the established criteria for DM. Nevertheless pre-diabetic patients
have important metabolic alterations that increase the risk for T2D de-
velopment [27] and associated complications. Besides mild glycemia,
pre-diabetic individuals also present impaired glucose tolerance and in-
sulin secretion as well as relative insulin insensitivity [27,28]. Thus,
special care must be taken in account when discussing the overall
effects of DM in any relevant physiological condition because the spec-
trum of development stages of this disease is very complex [29]. It is
also well known that DM alters the hypothalamic–pituitary–gonadal
axis, which is responsible for some of the problems related to DM,
such as impotence [16,30]. Earlier studies reported elevated pituitary
gonadotrophins in diabetic rats [31] and altered levels of LH and FSH
[32,33]. Moreover, diabetic rats have abnormal sexual steroids feedback
in the hypothalamic–pituitary axis described as a consequence ofabnormal steroid transport or reduced pituitary sensitivity [15,34]. Sev-
eral reports also demonstrated that DM is associatedwith hormonal de-
regulation, particularly of sex steroids hormones [35–37].
In summary, DM is a metabolic disease that is growing to epidemic
proportions. Besides, there are several co-morbidities that highly in-
crease the complexity of the disease. The human and economic costs
of such a wide spectrum disease are beyond estimations, making DM
a preferential spotlight for researchers all over the world.
3. Molecular basis of glucose metabolism in testis and sperm
Blood glucose concentrations depend on and alter the function of
several organs and tissues. Liver and fat are usually known to suffer
a tight control from glucose ﬂuctuations, especially because they are
known to play key roles in the use and storage of nutrients by hor-
monally regulated mechanisms. In testes, glucose metabolism is also
a pivotal event. Moreover, spermatogenesis maintenance in vivo de-
pends upon glucose metabolism [38] although there are low levels
of this sugar in tubular ﬂuid [39]. Therefore, blood-to-germ cells
transport of glucose and other metabolic intermediates is highly con-
trolled, particularly due to the presence of the blood–testis barrier
(BTB). This barrier not only physically divides the seminiferous epi-
thelium in two compartments but also is responsible for the mainte-
nance of different levels of substances and metabolites between rete
testis ﬂuid and the lymph or plasma [40]. One of the most relevant
testicular cells for all the functions of BTB is the Sertoli cell (SC).
These cells have such an important role on male reproductive func-
tion that their number is usually associated with testis size [41] and
they play a broad spectra of functions in the spermatogenic event.
Besides being responsible for water transport from the interstitial
space to the lumen [42], they also control the seminiferous ﬂuid
pH and ionic composition [43–45]. Furthermore, SCs are known as
“nurse cells” because they provide physical and nutritional support
for the developing germ cells, which is pivotal for a normal spermato-
genesis [46]. SCs are well known for their ability to produce lactate at
a high rate [39,46–50] that is consumed, together with pyruvate, by
pachytene spermatocytes and round spermatids [46,47,51] (Fig. 1).
Glucose passive transport across BTB, mediated by glucose trans-
porters (GLUTs), is an important event to spermatogenesis. In SCs, the
main components of BTB, GLUT1, GLUT3 and GLUT8 isoforms have
been identiﬁed [52,53]. GLUT1 and GLUT3 expression proved to be sensi-
tive to several substances such as hormones, cytokines or growth factors,
which are known to regulate glucose uptake by SCs [49,50,53,54]. Recent
in vitro studies reported thatwhenglucose [55] or insulin [54] is removed
from extracellular medium, SCs are capable to adapt their glucose trans-
port machinery in order to ensure the appropriate lactate production.
In these processes, lactate dehydrogenase (LDH) is pivotal for the
continued ATP production by glycolysis. Moreover, germ cells express
a speciﬁc isozyme of LDH, known as LDH type C (LDHC) that is abundant
in spermatids and spermatozoa [56,57]. After glucose uptake by SCs and
the conversion of pyruvate to lactate by LDH, it is imperative that this
product of glycolysis becomes available for the developing germ cells.
This event is mediated by active membrane monocarboxylate trans-
porters (MCTs) that are responsible for lactate transport through the
plasmamembrane of SCs [49,54,55,58] (Fig. 1).We [49,50,59] and others
[53,60,61] reported that the testicular cells metabolic cooperation is
under strict hormonal control leading us to conclude that the hormonal
control of SCsmetabolism is pivotal for spermatogenesis [62]. Therefore,
understanding SCs energymetabolismmayhelp to identify andpromote
new therapeutic approaches against subfertility or infertility caused
by pathological conditions as spermatogenesis is in the basis of male
fertility.
The molecular basis of glucose metabolism and the importance
of its subproducts in testis are far beyond the simple maintenance
of the germ cells nutritional status. In fact, a vast majority of patients
suffering from subfertility and infertility have problems in sperm
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maintained by several glycolytic and non-glycolytic substrates since
both glycolysis and mitochondrial respiration are active in mammalian
sperm [64]. However, sperm capacitation is known to be stimulated by
glucose [65], evidencing the regulatory role that this sugar can exert in
the overall male reproductive function. Importantly, the loss of sperm
functional competence is often associated to oxidative stress that arises
from sperm metabolism [66], since sperm capacitation is achieved by
biochemical and metabolic modiﬁcations.
4. Diabetes-related male subfertility/infertility
4.1. Clinical data
Recently, a high prevalence (51%) of subfertility was reported
among patients with DM [67]. This led to the perception that DM isFig. 1. Schematic illustration of the metabolic cooperation between Sertoli and germ cells. Th
mainly GLUT1 and GLUT3, and is converted into glucose-6-phosphate that is then converted
into the mitochondrial matrix to form acetyl-CoA; b) converted into lactate by lactate dehy
lactate produced by Sertoli cells is exported to the intratubular ﬂuid by proton-linked pla
produced by Sertoli cells through MCTs, which is then directed for ATP production.responsible for inducing subtle but crucial changes in sperm quality
and function [68]. It is well known that in men DM is responsible
for important sexual disorders such as decreased libido and impo-
tence [69]. Erectile dysfunction (ED) is also very prevalent in diabetic
men [70], but it ultimately depends on the male age, the duration
of the disease and the level of blood glucose levels control. In a
population-based cohort study, there was an increase of ED in older
men with DM [71] and it has been reported that the glycemic control
is correlated with ED [72]. Ejaculation disturbance is another factor
that has been long identiﬁed in men with DM, especially retrograde
ejaculation [73,74], a condition where semen passes backwards into
the bladder.
Diabetic male reproductive capacity is undoubtedly affected by ED
and retrograde ejaculation, but when studying sperm parameters and
sperm quality markers, the literature shows some conﬂicting results.
In the 70s a study involving 25 diabetic individuals and 24 controle glucose from the interstitial ﬂuid enters the Sertoli cells through glucose transporters,
into pyruvate by phosphofructokinase (PFK). The pyruvate can then be: a) transported
drogenase (LDH); or c) converted into alanine by alanine aminotransferase (ALT). The
sma membrane transporters (MCTs), mainly MCT4. The germ cells uptake the lactate
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lower sperm values and signiﬁcant differences in sperm motility and
morphology [75]. A few years later, other study compared the ejaculat-
ed of 65 diabetic and 77 control men and it was reported a negative ef-
fect of DM in the ejaculated. The parameters mostly affected were, in
decreased order, sperm motility, morphology, volume and count [76].
Slightly different results were reported in a 1984 study, where T1D
adolescents presented a minor, non-signiﬁcant, decrease in sperm
count relatively to control individuals [77]. The semen from these T1D
adolescents had lower volume andmotility, as well as alteredmorphol-
ogy, and presented signiﬁcantly higher fructose and glucose levels,
evidencing that an ineffective metabolic control can be deleterious
and/or responsible for the observed alterations in the semen [77].
Later, a study in testicular biopsies from impotent men with DM, con-
cluded that the testes of impotent diabeticmenpresented ultrastructur-
al lesions in apical SC cytoplasm and morphological changes in the
interstitial compartment, thus suggesting spermatogenic disruption
and subfertility or infertility problems [78]. Another work reported
that T1D and T2D subjects had a signiﬁcant increase in sperm count
and concentration, and a signiﬁcant decrease in sperm motility and
semen volume [77]. Interestingly, the spermmorphology and the qual-
ity of spermmotility remained unaffected [79]. Spermatozoamotility of
T1D patients was also evaluated by Niven et al. using a computerized
image analysis system [80]. They reported no correlations between
sperm motility and age, age of onset of DM and duration of DM. None-
theless, when comparing the diabetic group with control subjects, they
concluded that several parameters related to sperm motility, such as
track speed, path velocity, progressive velocity, and lateral head dis-
placement, were not altered. On the other hand, other sperm motility
related parameters, such as linearity and linear index that analyze the
straightness of swimming, were signiﬁcantly increased in diabetic
men [80]. The controversy about the real impact of DM in male repro-
ductive health continued, and, in 2002, a sperm cryopreservation
study of patients with several diseases, including DM, reported that
only the sperm from diabetic men presented signiﬁcant differences in
sperm parameters, namely in sperm counts [81]. More recently, a
study with both T1D and T2D patients reported that diabetic men
may present normal semen parameters, or only a signiﬁcant decrease
in semen volume, but they have a higher level of damage in sperm nu-
clear and mitochondrial DNA than control individuals [5].
There are apparently contradictory results concerning sperm
motility and other male reproductive parameters when studying
male diabetics. In fact, the conﬂicting nature of the existing data
should be clariﬁed. The fact that most of these studies are more fo-
cused on the clinical signiﬁcance, rather than the molecular mecha-
nisms behind DM-induced alterations, may explain at some extend
the lack of consensus. For instance, the conventional semen analysis
that was used in several of these studies, has been recognized by
some authors, as very limited in the determination of the fertility
status [82]. Moreover, there are several factors very difﬁcult to con-
trol such as the duration of the disease, the glycemic control, the
type of treatment as well as all the comorbidities associated to DM
that mask the outcomes of the works related with DM and male fer-
tility. Molecular studies with sperm from diabetics are still scarce
and most of the mechanisms through which sperm manage to attain
their energy metabolism in diabetic men remain to be disclosed.
Therefore, there is an urgent need for more studies focused on the
molecular mechanisms beyond glucose transport in sperm of diabetic
men. However, there is a more profound lack of literature concerning
the effect of DM in the functioning of testicular cells. It is expected
that the metabolic cooperation between testicular cells may be
compromised. To surpass these issues, as experimentation in humans
has great restrictions and in most cases the tested hypotheses are im-
possible to assess in human material, the use of animal models that
allow a tight control over experimental conditions are of extreme
importance.4.2. Animal models data
Interestingly, data from animal models are successful in demon-
strating that DM impairs male fertility and it is responsible for alter-
ations in the reproductive health of individuals. As expected, there are
more studies with animal models than with clinical data concerning
DM-related male infertility. Since the 70s there are studies reporting a
reduced fertility in male diabetic rats [83] and in the early 80s several
reports using BB Wistar rats, a strain that spontaneously develop DM,
described gonadal dysfunction in these animals [84,85]. A few years
later the ﬁrst study with a DM rat model induced by streptozotocin
(STZ) and insulin therapy was done, reporting that STZ-treated rats
presented decreased sperm counts and motility and that insulin treat-
ment was able to restore these parameters [86]. This study evidenced
that glycemic control may play a key role in reducing DM-related
subfertility or infertility problems. Concomitant with that hypothesis,
it was reported in the early 90s that long-term DM with sustained
uncontrolled hyperglycemia is responsible for testicular dysfunction,
resulting in decreased fertility potential [87]. Later, it was described
that STZ-induced DM male rats have altered sex behavior and dimin-
ished reproductive organ weight, testicular sperm content, epididymal
sperm content, aswell as spermmotility [88]. Studies on STZ-treated di-
abetic rats also showed that DM may cause regression of epididymis,
leading to a decrease in caput weight, corpus, and caudal regions.
Those studies also described atrophic changes in the caput, corpus,
and caudal epididymis that resulted in voiding of spermatozoa from
the epididymal lumen [89]. Insulin treatment was able to prevent
some of these deleterious effects but only on certain epididymal regions
[89]. Additionally, others studied the fertilization ability of spermatozoa
frommale STZ-induced diabetics and reported that these animals had a
signiﬁcant reproductive dysfunction that resulted from a decrease in
the reproductive organ weights and in sperm counts, though not
compromising sperm fertilizing ability using in utero insemination
[90]. Also, a study comparing T1D and T2D using STZ-treated and
Goto–Kakizaki (GK) rats showed that hyperglycemia had an adverse ef-
fect in sperm concentration and motility [91]. More recently, Kim and
Moley [92] studied diabetic male mice sperm quality and fertilization
capacity as well as subsequent embryo development. They concluded
that DM decreased sperm concentration and motility and may cause
male subfertility by altering steroidogenesis [92]. Others reported that
the offspring of diabetic female rats, presented altered testicular param-
eters during fetal life, which can affect reproductive health during post
puberty [93]. The offspring males presented increased number of sem-
iniferous tubules besides thickness of the testicular capsule and reduced
number of Leydig, Sertoli and spermatogonia cells [93].
Although there are contradictory results concerning sperm motil-
ity and other male reproductive parameters in diabetic men, it seems
more consensual that DM rat models present signiﬁcant alterations
that end-up in reduced male reproductive health (see Table 1 for de-
tails). Nevertheless, most of the works are not actually focused on the
molecular mechanisms beyond glucose deregulation. The pathologi-
cal alterations induced throughout the male reproductive tract of ro-
dents are diverse in nature and although the histological changes are
evident, most of the biochemical changes remain unknown. Thus, it is
imperative to disclose the molecular mechanisms behind testicular
cells metabolic dysfunction caused by DM to identify key points for
possible therapeutic interventions.
5. Role of insulin dysfunction in male infertility
Euglycemia is very difﬁcult to achieve in diabetic individuals al-
though glycemic control is crucial to reduce DM-related complications
[22]. In fact, hypoglycemia and the correlated hyperinsulinemia are
common events in diabetic individuals. Glucose and insulin ﬂuctuations
lead to important molecular alterations that may result in detrimental
effects to the reproductive health of the diabetic men. The undesirable
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of the disease progression but hyperinsulinemia and hypoglycemia are
common in both T1D and T2D [94,95]. Moreover, throughout the dia-
betic individual's life, especially T2D subjects, become progressively
more insulin deﬁcient and, consequently, more vulnerable to the unde-
sirable effects of a poor glycemic control. Furthermore, contrarily to
non-diabetic individuals that are very sensitive to small glucose or insu-
lin variations in plasma, diabetic individuals gradually lose their sensi-
tiveness to glucose and insulin [96,97]. This is very important because,
as discussed earlier, the number of diabetic adolescents is increasing
and their reproductive health may be compromised at a very early
age. Noteworthy, although the use of insulin analogs and/or insulin is
essential they do not guaranty total effectiveness. In addition, insulin
therapy can be a double-edged sword and its safety has been questioned
[23–25]. Thus, it is imperative to discuss the molecular mechanisms al-
tered in testicular cells when insulin deregulation occurs.
Few studies have been focused on the molecular mechanisms that
are altered in testicular cells by insulin deregulation. In the early 80s
the ﬁrst studies concerning the effect of insulin in SCs glucose metabo-
lismwere published. Initially, it was reported that insulin acted synergis-
tically with other hormones but its importance to male reproduction
remained unknown [98]. Others reported that insulin stimulated the up-
take of total nucleotide pool and in ATP, GTP, and UTP pools [99] as well
as transferrin secretion by SCs [100]. Then, it was reported that insulin at
micromolar concentrations induced stimulatory effects not only in DNA
and protein synthesis but also in SCs lactate production [101]. Later, it
was reported that after 3 h of insulin addition to SCs, they showed a
marked stimulation of lactate production [102] (Fig. 2). This insulin ef-
fect on cultured immature rat SCs was described as being mediated by
insulin receptors [102] (Fig. 2), however it was only a few years later
that the authors reported not only the presence of insulin receptors but
also suggested that insulin and insulin-like growth factor-I (IGF-I) had
precise functions responsible for the regulation of speciﬁc SCs activitiesTable 1
Summary of the main studies reporting diabetes-related reproductive effects.
Model
Animal studies Genetic models BB rat
GK rat
Chemically-induced models STZ rat
ALX rat
Clinical studies
Legend: BB rat — BioBreeding genetic rodent model; GK rats — Goto–Kakizaki genetic rode
rodent model. T1D — type 1 diabetes; T2D — type 2 diabetes; — increase; — decrease;during spermatogenesis initiation and maintenance [103,104]. Interest-
ingly, Leydig cells cultured in a Sertoli cell-conditioned medium had
also their functions controlled by the presence or absence of insulin
[105]. In the 90s it was reported that insulin could not only regulate gly-
cinemetabolism but also lipid metabolism in cultured SCs [106]. Later, a
study in SCs and Leydig cells of STZ-treated rats, evidenced that the bio-
synthesis of arachidonic acid, a polyunsaturated fatty acid essential for
several cellular functions, was under insulin regulation [107] (Fig. 2).
Importantly, it was reported that insulin could promote the differentia-
tion of spermatogonia into primary spermatocytes by binding to the
IGF-I receptor [108]. More recently, it was suggested that insulin re-
stores the reproductive health in diabetic males by the normalization
of the hypothalamic–pituitary–gonadal axis, and thus via the LH and tes-
tosterone levels, rather than having a direct interaction in the testis
[109]. However, it was also recently reported that insulin deprivation in-
duced several important metabolic alterations in cultured SCs [54,59].
Insulin-deprived cultured SCs presented lower glucose consumption
that was followed by a lower lactate production, down-regulation of
metabolism-associated genes of lactate production and export and also
an intriguingmodulation of GLUT1 andGLUT3 [54] (Fig. 2). Noteworthy,
acetate secretion,which is also reported to be one of themajor SCs func-
tions, was completely suppressed in SCs cultured under insulin depriva-
tion conditions [59]. Although the exact meaning of this mechanism to
spermatogenesis was not completely disclosed, the reduction of acetate
production, necessary for the continuous membrane remodeling that
occurs in the developing germ cells,may compromise the spermatogen-
ic event.
Insulin role on themale reproductive tract goes far beyond testicular
cells. In the 70s the ﬁrst studies pointed to a stimulation of hexoses me-
tabolism by sperm under insulin action [110]. However, the discussion
continued whether insulin could modulate sperm metabolism or not
with a study reporting that spermatozoa glucose oxidation could be in-
dependent from extracellular glucose concentration and insulin wasType of diabetes Reproductive effects
T1D Testis weight [87]
Severe germ-cell depletion [85]
Serum testosterone [85,87]
Disruption of seminiferous tubular morphology [85,87]
Sertoli-cell vacuolization [85]
Sperm production [87]
Fertility [84,87]
T2D Sperm production [91]
T1D Testis weight [86,90]
Disruption of epididymis morphology and density [89]
LH, FSH and testosterone serum levels [86,88,90]
Sperm production [88,89]
Sperm counts and motility [86,88,90–92]
Erectile dysfunction [70]
Ejaculation dysfunction [88,90]
Mating behavior [88,90]
Fertility [90,92]
T2D LH, FSH and testosterone serum levels [93]
Disruption of seminiferous tubular morphology [93]
Number of Leydig and Sertoli cells [93]
Number of spermatogonia [93]
T1D Disruption of seminiferous tubular morphology [78]
Germ-cell depletion and Sertoli-cell vacuolization [78]
Disruption of blood–testis barrier [78]
Erectile dysfunction [70,76]
Ejaculation dysfunction [73,74]
Semen volume [76,77]
Sperm counts, motility and morphology [75–77]
T2D Erectile dysfunction [69]
Semen volume [5,79]
Sperm motility [79]
Sperm DNA fragmentation [79]
nt model; STZ rat — Streptozotocin-induced rodent model; ALX rat — Alloxan-induced
superscript numbers are references as indicated in references section.
Fig. 2. Schematic illustration of the insulin action in Sertoli cells metabolic pathways. The insulin effects, mediated by its interaction with insulin receptors, can induce several effects
in metabolism-associated transporters. Some of those effects can be stimulatory, such as in monocarboxylate transporter 4 (MCT4), glucose transporter 3 (GLUT3), lactate
dehydrogenase (LDH), acetyl-CoA synthase and acetyl-CoA hydrolase; while other effects can be inhibitory such as in glucose transporter 1 (GLUT1) and arachidonic acid synthesis.
⊕ — stimulatory effect; ⊖ — inhibitory effect.
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[111]. A few years later, it was reported that both plasma membrane
and the acrosome of spermatozoa are targets for insulin action and
thus are under insulin hormonal control [112]. Also, intratesticular in-
jection of insulin resulted in a decrease in spermatozoa motility in vas
deferens and an increase in motile spermatozoa percentage on incuba-
tionmedium after removal [113]. Moreover, defects in insulin secretion
may change testicular and sexual glands function [114]. Interestingly,
a study about the incidence of insulin resistance in men with ED, con-
cluded that these men have a high incidence of insulin resistance thus
evidencing a possible role for insulin in the reproductive health of
men [115]. Others also reported that in men with increased insulin re-
sistance there is a decrease in Leydig cell testosterone secretion and,
thus, severe male reproductive dysfunction [116]. Importantly, a recent
study from Aquila et al. [117] proved that not only human ejaculated
spermatozoa secrete insulin, but also that there is a physiological role
for this insulin in the autocrine glucose metabolism regulation. This
ﬁnding opened a new possible role for insulin in spermatozoacapacitation by controlling their glucose metabolic pathways. Others
have also reported that insulin treatment in washed human spermato-
zoa from normozoospermic donors signiﬁcantly increased total and
progressive motility and acrosome reaction, as well as nitric oxide
(NO) production, thus evidencing that insulin can enhance human sper-
matozoa fertilization capacity [118]. Moreover, a mitochondrial citrate
carrier that contributes to the acquisition of sperm fertilizing ability
through insulin secretion control has been identiﬁed [65], showing
that insulin can act in sperm metabolism in a more complex way than
the ﬁrst proposed mechanisms.
In sum, from the literature overview, we conclude that insulin
dysfunction has a crucial role in male infertility and/or subfertility re-
lated to DM and it is vital to study how insulin and insulin analogs
therapy is administered and used to maintain the glycemic control.
Moreover, insulin-induced hypoglycemia, a phenomenon that is fre-
quent and in some rare cases fatal, has unpredictable effects in the
overall metabolism of testicular cells. In fact, neither the magnitude
of insulin dysfunction nor the mechanisms by which insulin controls
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should deserve more attention in the future.
6. Molecular mechanisms of testicular glucose metabolism in
diabetic conditions
There is no doubt that spermatogenesis is ametabolically active pro-
cess that depends upon strictmetabolic cooperation between the sever-
al testicular cell types. During spermatogenesis, spermatozoa are
produced within the seminiferous tubule in a process that takes several
days and is under endocrine and paracrine control through the SCs [10].
In addition, SCs are responsible for the conversion of glucose, a non-
metabolized substrate by developing germ cells, in lactate which is the
preferential substrate for those cells. The molecular mechanisms of tes-
ticular glucose metabolism in diabetic conditions are far from being
disclosed. Nevertheless, in vitro andmorphological studies of human bi-
opsies from diabetic men allowed the collection of small but vital infor-
mation concerning those molecular mechanisms. Human biopsies from
diabetic men showed that there are morphological changes in testicular
cells, namely in SCs, which presented extensive vacuolization and had a
high degree of degeneration [78]. Moreover, germ cells exhibited a nor-
mal morphology, but the seminiferous tubules were depleted, and the
number of Leydig cellswas also very variable,with these cells presenting
lipid droplets and variable number of vacuoles [78]. All these changes
certainly have dramatic consequences to testicular cells glucose metab-
olism and to the overall metabolic cooperation between SCs and devel-
oping germ cells. In fact, impairment of glucose metabolism is often
related with increased fatty acid metabolism. Early studies reported
that DM caused an increased endogenous oxygen uptake and reduced
lactate production by testicular cells [119]. The same study also reported
that DM increased cholesterol, non-esteriﬁed fatty acids, triglycerides
and phospholipids in rat testis tissues [119]. In the 80s, Hutson [120]
studied the biochemical responses of rat SCs and peritubular cells cul-
tured under simulated diabetic conditions and reported that the in
vitro metabolic functioning of these testicular cells was very sensitive
to glucose concentrations. In fact, SCs cultured with high glucose con-
centration increased lactate secretion. At that time, it had already been
reported that lactate enhanced respiration rates and protein and RNA
synthesis in isolated pachytene spermatocytes and round spermatids
[47], by interacting in other metabolic pathways and producing adeno-
sine triphosphate (ATP) [121]. Besides, lactate was also described as a
modulator of nicotinamide adenine dinucleotide phosphate-oxidase
(NADH) oxidation and the pentose phosphate pathway in those cells
[122]. In the 90s, new functions for the lactate produced in the testis
were described. Intratesticular lactate infusion was reported to improve
the spermatogenesis in adult cryptorchid rat testis [123] and later, it was
described that germ cell death is inhibited in a dose-dependent way by
lactate [124]. Therefore, any condition that promotes an alteration in
testicular lactate levels or lactate production by SCs may compromise
germ cell development and this can occur through several distinct
mechanisms.
Recently, in vitro works focused on the molecular mechanisms of
glucose or insulin deprivation in SCs. It was reported that decreased
glucose levels in SCs culture medium increases glucose uptake to
maintain lactate production, which was only slight decreased [55].
This was achieved by modulating GLUT1 and GLUT3 expression,
through activation of AMP-activated protein kinase (AMPK), phos-
phatidylinositol 3-kinase (PI3K)/PKB, and p38 MAPK-dependent path-
ways [55]. The authors do not infer about possible alterations in the
key steps of glycolysis. One of those steps would be the conversion of
fructose 6-phosphate to fructose 1,6-biphosphate by phosphofructoki-
nase (PFK) as well as LDH action, which is responsible for the intercon-
version of lactate into pyruvate. Finally, the effect on the mechanisms
of lactate export by MCTs remained to be elucidated. Nevertheless,
that work was pioneer in evidencing that SCs can adapt their glucose
metabolism bymodulating GLUTs expression. Interestingly, as discussedearlier, the same behavior in GLUTs expression was recently described
in human SCs cultured in insulin deprivation conditions [54]. That
work was one of the ﬁrst attempts to disclose the mechanisms by
which insulin deprivation or insulin resistance, that are common DM
features, alter carbohydrate metabolism, namely glucose metabolism.
In insulin-deprived cells, total glucose uptake was not altered, mainly
due to the discussed GLUTs adaptation, but pyruvate consumption
was compromised. The insulin-deprived cells not only stopped to con-
sume pyruvate but also started to produce this substrate that was
then exported into the extracellularmedium [54]. Consequently, lactate
productionwas compromised and twomechanisms of lactate metabol-
ic control were found to be altered: LDH and MCT4. Moreover, it was
later proposed that SCs could produce and export acetate to the devel-
oping germ cells and that this acetate production was regulated by ex-
ternal insulin [59]. In fact, it was reported that cultured human
SCs secreted high amounts of acetate that was suppressed by insulin
deprivation, through a mechanism mediated by the modulation of
acetyl-CoA synthase and acetyl-CoA hydrolase expression. Therefore,
at least in vitro, the molecular mechanisms of testicular glucosemetab-
olism are severely altered by glucose and insulin ﬂuctuations in ways
that can compromise spermatogenesis.
Although the exactmechanisms by which DM alters the glucoseme-
tabolism in testicular cells are not easy to follow in vivo, in vitro evidence
cannot be disregarded. As discussed above, it is well known that DM is a
metabolic disease that induces crucial alterations in sex hormones levels
[125]. Recent work in both rat and human SCs showed that their energy
metabolism is inﬂuenced by sex steroid hormones. Cells treated with
5α-Dihydrotestosterone (DHT) consumed less glucose and thus, pro-
duced less lactate. Both, 17β-estradiol (E2) and DHT were able to alter
lactate metabolism-associated gene transcript levels such as MCT4,
LDH and also GLUTs [49,50]. Moreover, sex steroids are also known to
regulate apoptotic signaling pathways in SCs, thus, deregulated levels
of these hormones may lead to apoptosis and necrosis [126,127]. None-
theless, when analyzing all these molecular mechanisms that are cer-
tainly related to DM pathological conditions, one cannot neglect the
possible contribution of glycogen. It has been reported that SCs possess
glycogen and glycogen phosphorylase activity [128,129] but these re-
ports from the 80s were not consolidated and therefore should deserve
special attention in a near future to understand the adaptive mecha-
nisms of SCs in pathological conditions. The presence of glycogen and
glycogen metabolism related machinery can be a valuable mechanism
to explain some of the assumptions concerning DM-related effects in
glucose metabolism of testicular cells.
7. Role of alternative fuels and oxidative stress in testis from
male diabetics
As discussed earlier, euglycemia is very difﬁcult to achieve andmain-
tain in diabetic individuals that often face hyper- and hypoglycemia.
Those ﬂuctuations in insulin and glucose concentrations lead to several
problems. Under glucose deprivation and/or insulin deregulation, testic-
ular cells are expected to suffer metabolic adaptations and use alter-
native substrates. In fact, the role of these alternative substrates is
underestimated when analyzing some of the available data. SCs have
an enormous metabolic plasticity and can use several metabolic sub-
strates such as palmitate and ketone bodies as well as glutamine, ala-
nine, leucine, glycine and valine [130,131]. Besides, these cells can
produce ATP via the β-oxidation of free fatty acids or even through
recycled lipids from apoptotic spermatogenic cells and residual bodies
[132]. DM is known to induce severe alterations in lipid metabolism
and studies in mice with inactivated genes of lipid metabolism proved
that lipid metabolism is essential for a normal spermatogenesis [133].
Therefore, although there is a lack of literature regarding the use of
these alternative substrates in testicular cells of diabetic individuals,
we cannot disregard their contribution to the overall metabolic dysfunc-
tion that occurs in the testis of diabetic individuals.
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stress due to the overproduction of reactive oxygen species (ROS) and
decreased antioxidant efﬁciency [134]. This is a direct consequence of
increased glycolytic capacity induced by higher glucose availability.
Therefore, in testicular cells such as SCs where glucose metabolism is
very active to produce lactate, it is expected increased levels of oxida-
tive stress. This is an issue that deserves special attention in the near fu-
ture because ROS generation has a real potential toxic effect in sperm
quality and function. High levels of ROS are reported to be detrimental
to fertility potential in natural and assisted conception [135]. Moreover,
ROS production stimulated by hyperglycemia is recognized as a major
cause for the clinical complications associated with DM and obesity
[136]. Hyperglycemia-induced superoxide overproduction inhibits
glucose-6-phosphate dehydrogenase [137] thus decreasing the antiox-
idant defenses and ROS overproduction and is also intimately related
withmitochondrial dysfunction. It has been reported thatmitochondri-
al ﬁssion/fusionmachinery is sensitive to the increased ROS production
after hyperglycemia stimulation [138] and mitochondrial testicular an-
tioxidant capacity is also known to be modulated by DM as an adaptive
response to the increased oxidative stress [139]. In fact, hyperglycemia
was reported to induce important alterations in sperm concentration
and motility by altering energy production and free radical manage-
ment [91], which is associated with the fact that human spermatozoa
are known to be highly sensitive to oxidative stress. Sperm plasma
membrane and nuclear or mitochondrial DNA fragmentation also
occur in response to ROS, compromising the fertility potential of the
individuals [140]. Increased sperm DNA damage was reported in dia-
betic men in reproductive age and associated to high oxidative stress
resulting from sperm overexposure to glucose [5]. These mechanisms
of sperm nuclear DNA damage in diabetic men promoted by ROS are
suggested to be mediated through advanced glycation end products
(AGEs) [141] and these AGEs accumulate in the reproductive tract of
diabetic men [142]. Moreover, increased oxidative stress and higher
DNA fragmentation is interconnected with apoptosis [143,144], which
has been reported to be increased in sperm from T1D and T2D men
and suggested as a possible mechanism to explain subfertility in these
individuals [145]. Recently, a possible central role for ROS in the patho-
genesis of insulin resistance has also been highlighted [146], thus
evidencing that ROS production stimulated by DM may have roles
that go far beyond the glucose transport and metabolism.
8. Conclusion
It is obvious that not all diabetic men are infertile and there are
conﬂicting results concerning the effect of DM in sperm parameters
but, even when conventional sperm parameters do not differ, the glu-
cose transport mechanisms are expected to be altered. Glucose avail-
ability and/or insulin dysfunction induced by DM are expected to
induce important metabolic adaptations in testicular cells, besides
changes in oxidative stress that are often reﬂected in mitochondrial
and nuclear DNA fragmentation. Moreover, glucose metabolism is
as important for testicular cells as for mature sperm. In fact, sperm
hyperactivation and/or capacitation depend of this substrate, although
it is not clear if glucose is necessary for direct energy production or as
a precursor for other metabolic products [147]. Besides, it remains to
be disclosed the mechanisms responsible for the DM-induced alter-
ations in these processes. Althoughwehave to admit that froma clinical
perspective the knowledge of the molecular mechanisms beyond glu-
cose transport are not as appellative as DNA integrity and oxidative
stress, which seem to have a more direct effect in natural and assisted
conception, disclosing the pathways by which the chronic metabolic
changes, beyond glucose transport, are altered by DM in testicular
cells, will open new possibilities for pharmacological intervention. The
presence of several DM-related comorbidities also complicates the
study of DM-induced alterations in testicular cells and sperm. Most of
the time the patients are treated in a polypharmacy regimen and theinappropriate use of these agents are associated with signiﬁcant mor-
bidity and mortality [148]. This is a crucial point that, in some cases, is
not correctly weighed in clinical studies. The possible subtle molecular
alterations in the male reproductive health promoted by pharmacolog-
ical agents currently used in DM treatment should also deserve special
attention in the near future.
In conclusion, the effects of DM on the molecular mechanisms
responsible for the maintenance of the male reproductive health
have been somewhat neglected, apart from the concerns about impo-
tence, semen quality and, at some extend, oxidative stress and DNA
fragmentation. Nevertheless, studies on the molecular mechanisms
beyond glucose transport in DM-related male infertility will be on
the spotlight in the next few years to uncover the metabolic plasticity
in sperm and testicular cells of diabetic individuals. This will certainly
be a step forward for a possible metabolic therapeutic intervention.Acknowledgements
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